(ARGX) Argen-X - Performance 54.8% in 12m
Compare ARGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
88.93%
#3 in Group
Rel. Strength
90.95%
#728 in Universe
Total Return 12m
54.77%
#27 in Group
Total Return 5y
293.97%
#8 in Group
P/E 45.1
86th Percentile in Group
P/E Forward 82.6
90th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.25%
79th Percentile in Group
12m Total Return: ARGX (54.8%) vs XBI (-2.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8% | 23.5% | 161% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
2.55% | 23.2% | 41.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-8.48% | 7.43% | 35.1% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
0.56% | 12.5% | 38.1% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.7% | 17.1% | 0.22% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-8.13% | -22.5% | 4.98% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-5.51% | 32.3% | -8.24% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
6.82% | -5.27% | 21% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
| Total Return (including Dividends) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.15% | -7.84% | -4.31% |
| 3 Months | -14.68% | -13.34% | -7.85% |
| 12 Months | 54.77% | -2.25% | 10.76% |
| 5 Years | 293.97% | -18.04% | 106.31% |
| Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
| 1 Month | -46.2% | -17.6% | -35.6% |
| 3 Months | -92.2% | -91.9% | -89.7% |
| 12 Months | 83.8% | -36.5% | 58.3% |
| 5 Years | 91.0% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #79 | 4.01% | 0.17% |
| 3 Month | #75 | -1.55% | -7.41% |
| 12 Month | #26 | 58.3% | 39.7% |
| 5 Years | #8 | 381% | 91.0% |
FAQs
Does ARGX Argen-X outperforms the market?
Yes,
over the last 12 months ARGX made 54.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months ARGX made -14.68%, while XBI made -13.34%.
Over the last 3 months ARGX made -14.68%, while XBI made -13.34%.
Performance Comparison ARGX vs Indeces and Sectors
ARGX vs. Indices ARGX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.70% | 0.16% | 7.14% | 44.0% |
| US NASDAQ 100 | QQQ | -6.66% | 0.09% | 7.14% | 42.8% |
| US Dow Jones Industrial 30 | DIA | -2.63% | 1.63% | 6.88% | 47.8% |
| German DAX 40 | DAX | -2.04% | -0.34% | -11.3% | 31.3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.83% | -0.65% | 8.56% | 46.2% |
| Hongkong Hang Seng | HSI | -2.43% | -1.27% | 5.27% | 40.8% |
| India NIFTY 50 | INDA | 2.73% | -5.71% | 5.54% | 53.0% |
| Brasil Bovespa | EWZ | -4.45% | -6.12% | 2.64% | 60.3% |
ARGX vs. Sectors ARGX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.56% | 1.43% | -1.60% | 32.4% |
| Consumer Discretionary | XLY | -7.05% | -0.11% | 3.98% | 40.4% |
| Consumer Staples | XLP | 2.76% | -6.90% | 1.82% | 45.3% |
| Energy | XLE | -1.35% | 7.48% | 9.57% | 66.7% |
| Financial | XLF | -2.74% | 0.63% | -0.96% | 35.5% |
| Health Care | XLV | -1.68% | 0.82% | 9.15% | 54.5% |
| Industrial | XLI | -2.87% | -0.08% | 6.79% | 47.9% |
| Materials | XLB | -1.45% | 0.36% | 14.0% | 60.1% |
| Real Estate | XLRE | 0.13% | -2.24% | 9.29% | 39.7% |
| Technology | XLK | -8.51% | 0.37% | 12.0% | 48.5% |
| Utilities | XLU | -0.55% | -5.83% | 4.04% | 34.3% |
| Aerospace & Defense | XAR | -4.26% | -3.85% | -4.13% | 27.8% |
| Biotech | XBI | -3.83% | 3.69% | 20.2% | 57.0% |
| Homebuilder | XHB | -2.95% | 1.87% | 22.1% | 62.7% |
| Retail | XRT | -1.91% | -1.22% | 11.3% | 58.4% |